Geron Corporation: Can Restructuring Bring The Stock Back To Life? I'm On Sidelines (GERN)

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?My last update on Geron ( GERN ) for Seeking Alpha was written in June, when shares in the commercial stage Pharma based in Foster City, California, traded at a value of $1.54, and its market cap was ~$1bn.Edmund I ...